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Abstract Coronary revascularisation has been a topic of
debate for over three decades in patients undergoing high-
risk non-cardiac surgery. The paradigm shifted from routine
coronary angiography toward stress test guided decision-
making based on larger randomised trials. However, this
paradigm is challenged by relatively newer data where rou-
tine coronary angiography and revascularisation is shown
to improve perioperative cardiovascular outcomes. We re-
view major studies performed over a long period including
more contemporary data with regard to the 2014 American
College of Cardiology/American Heart Association as well
as 2014 European Society of Cardiology guideline on peri-
operative cardiovascular evaluation of patients undergoing
non-cardiac surgery.
Keywords Coronary stenting · Perioperative ·
Revascularisation
Introduction
Cardiac risk stratification before any non-cardiac surgery is
a common reason for a cardiology consultation. Despite the
fact that current American College of Cardiology/American
Heart Association (ACC/AHA) guidelines on perioperative
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cardiac evaluation indicate that coronary revascularisation
before non-cardiac surgery should generally be reserved for
patients who have an indication for it independent of the
surgery, many more patients undergo coronary revasculari-
sation in the preoperative setting, who would not undergo
revascularisation otherwise [1]. These guidelines recom-
mend the use of risk factor indices (such as the Revised
Cardiac Risk Index (RCRI) and National Surgical Quality
Improvement Program (NSQIP) risk calculator) and func-
tional capacity of individual patients to guide further test-
ing in preoperative evaluation in patients at elevated risk
(>1 %) of perioperative major adverse cardiac events dur-
ing planned non-cardiac surgery. On the other hand, Euro-
pean Society of Cardiology (ESC) guidelines recommend
avoiding non-invasive testing in stable patients who have
undergone coronary artery bypass graft (CABG) surgery
within the last six years, based on the data from the Coro-
nary Artery Surgery study [2, 3]. Based on various obser-
vational studies including the landmark study by Hertzer
et al. in 1984, coronary revascularisation was associated
with improved perioperative cardiovascular outcomes dur-
ing non-cardiac surgery [4–8]. As stress testing techniques
were refined, further studies evaluated a stress test-guided
approach to risk stratify these patients to avoid the risks as-
sociated with invasive angiography [9, 10]. As a result, over
the years, most routine coronary angiography and revascu-
larisation procedures were supplanted by stress test-guided
procedures to a variable degree. However, despite their
shortcomings relatively newer trials have shown conflict-
ing results with the use of routine angiography [11, 12].
Nevertheless, a debate still exists regarding the interpre-
tation and applicability of information derived from these
trials, and many physicians still utilise individual practice
patterns, rather than an evidence-based approach. The dis-
cordance between opinions of two cardiologists can be as
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high as 54 % [13]. Part of the reason could be lack of incor-
poration of some newer trial data into the guidelines. The
purpose of this review is to delineate the pathophysiologi-
cal basis of perioperative myocardial ischaemia as well as
review contemporary studies on perioperative assessment
with particular emphasis on revascularisation vis-a-vis the
current ACC/AHA guidelines.
Pathophysiology of perioperative myocardial
infarction
Contributing factors
The pathophysiology of perioperative myocardial infarction
(MI) is multifactorial. Surgery can induce a stress response
in the body, with the release of pro-inflammatory and pro-
thrombotic mediators that may predispose to platelet aggre-
gation, plaque rupture, haemorrhage and subsequent infarc-
tion [14–16]. In addition, intraoperative hypotension due to
fluid shifts, blood loss anaemia, pain and tachycardia can
induce oxygen demand-supply mismatch in patients with
fixed perfusion defects [14, 15]. Perioperative pain triggers
sympathetic pathways, which could also produce myocar-
dial ischaemia, as evidenced by a study showing reduc-
tion in ischaemia with the use of morphine [17]. Finally,
based on ‘normal’ coronary angiograms prior to surgery in
patients with perioperative MI, the possibility of transient
coronary thrombosis and vasospasm also exists [18].
Impact of ischaemia duration
Prolonged subendocardial ischaemia, as determined by
episodes of prolonged ST-segment depression, has been
associated with a vast majority of perioperative myocar-
dial events [14–16, 19]. These were exclusively non-ST-
segment elevation MIs. In addition, the timing of preop-
erative MI seems to be greatest in the period immediately
after surgery and emergence from anaesthesia [14–16, 19].
Most troponin elevations occur within the first 12–24 hours
after surgery [20]. This correlates with the period where
tachycardia, alterations in blood pressure, pain and cate-
cholamine response tends to be highest. A study involving
vascular surgery patients showed reduced incidence of my-
ocardial ischaemia if the heart rate was controlled strictly
in the first 48 hours following surgery [21]. In a dog model
with fixed coronary stenosis but without ischaemia at rest,
sustained tachycardia triggered MI despite anticoagulation
[22].
Mechanism of perioperative MI
In an autopsy study on 26 patients with fatal periopera-
tive MI, plaque rupture was discovered in half of the pa-
tients [23]. In a recent study involving 66 patients with
perioperative MI, analysis of pre- and post-surgery coro-
nary angiograms showed 54.5 % of infarctions to be from
demand ischaemia, 25.8 % from thrombotic, and 19.7 %
from non-obstructive coronary artery disease without any
identifiable culprit lesion [24]. Another study reported by
Dawood and colleagues showed perioperative MI to occur
predominantly in patients with left main and triple-vessel
disease [25]. The severity of the underlying stenosis did
not appear to predict the site of the infarct. Similarly, Ellis
and colleagues found high-grade stenosis to be an uncom-
mon cause of perioperative MI [18]. They also reported
viable myocardial areas with collateralised total occlusions
to be the predominant site of perioperative myocardial in-
farctions. The extent of coronary artery disease (CAD) in
terms of the number of arteries involved as well as lumi-
nal irregularities in the coronary arteries correlated with the
risk of MI [18].
Role of preoperative coronary revascularisation
Risk index stratification and symptom status in guiding
management
Compared with the 2007 ACC/AHA guidelines which heav-
ily relied on the risk of surgery in determining the need for
further testing in CAD patients with poor functional capac-
ity, the 2014 guidelines incorporate both surgical and clini-
cal risk using NSQIP and RCRI risk models [26]. It might
be preferable to utilise both these risk models in a given
patient, as RCRI alone may not perform well in predicting
perioperative events in patients undergoing vascular surgery
[27].
Impact of prior revascularisation
For patients with stable asymptomatic CAD who are not
at high risk for perioperative cardiovascular events, current
ESC guidelines do not recommend routine angiography if
patients have undergone CABG in the past six years based
on data from Coronary Artery Surgery Study (CASS) [2,
3]. The retrospective analysis of results from the CASS
database involving 25,000 patients demonstrated that the
protective effect of CABG is more prominent in patients
with triple-vessel disease and/or low left ventricular ejection
fraction for at least six years. Of note, these 3368 operations
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Routine coronary angiography approach
Coronary Artery Revascularisation Prophylaxis (CARP),
which is the largest randomised trial to date, failed to show
a benefit for routine coronary revascularisation when com-
pared with medical management alone in reducing perioper-
ative or long-term mortality [28]. In contrast, a more recent
but smaller randomised controlled trial reported by Monaco
and colleagues revealed startlingly different results, favour-
ing a more systematic approach utilising routine preopera-
tive coronary angiography and revascularisation in an effort
to reduce major adverse events in the perioperative period
as well as better long-term survival compared with stress-
test based strategy (Table 1; [11]).
The CARP trial screened 5859 patients across 18 Veter-
ans Affairs (VA) hospitals scheduled for elective vascular
surgery [28]. All patients underwent routine coronary an-
giography based on either clinical assessment or non-inva-
sive stress testing. Patients found to have >70 % coronary
stenosis were randomised to revascularisation and medi-
cal management versus medical management only. Patients
with significant left main disease, severe aortic stenosis and
those with left ventricular ejection fraction <20 % were ex-
cluded. While only 9 % of the original cohort (510 patients)
were randomised, only 32 % of the randomised patients
had triple-vessel disease, and only 44 % had moderately
large areas of ischaemia on nuclear stress imaging. Ap-
proximately 60 % of the patients were asymptomatic from
a coronary standpoint. The study reported no benefit of
prophylactic coronary revascularisation in reducing periop-
erative or long-term mortality. However, the CARP trial
had limitations. By excluding patients who are likely to
have derived most benefit from revascularisation, what the
study failed to ascertain was whether patients with more
extensive CAD would actually benefit from prophylactic
revascularisation or not in the perioperative setting. Addi-
tionally, patients were selected for angiography only if they
had risk factors or an abnormal stress test, which precludes
detection of significant asymptomatic CAD in these high-
risk patients undergoing vascular surgery. Since atheroscle-
rosis is the common pathogenic mechanism in patients with
CAD and peripheral arterial disease, these patients are quite
likely to have significant disease in other vascular beds. For
instance, incidence of severe CAD in patients with carotid
artery disease can be as high as 72 % [29]. Another study
on patients undergoing revascularisation of lower extremity
peripheral artery disease demonstrated a 66 % incidence of
concomitant significant CAD [30]. A subgroup analysis of
109 patients from the CARP trial who underwent surgery
for abdominal aortic aneurysm (AAA) and had an abnor-
mal preoperative stress test, prophylactic coronary revas-
cularisation was associated with a reduced risk of death
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and nonfatal MI. Besides, ischaemia of the anterior my-
ocardium was a predictor of poor outcomes independent of
revascularisation [31].
In contrast to the CARP trial, two relatively recent tri-
als have tested a strategy of routine coronary angiography
followed by revascularisation as needed regardless of symp-
tomatic status, which demonstrated significant reduction in
cardiac adverse events perioperatively [11, 12]. In a trial in-
volving patients scheduled for carotid endarterectomy, pa-
tients were randomised to routine coronary angiography
versus none in patients without any history or symptoms
of CAD. The results demonstrated that routine coronary
angiography followed by prophylactic coronary revascu-
larisation reduced the incidence of postoperative cardiac
ischaemic events [12]. Similarly, an older study on pa-
tients undergoing open repair of AAA showed improved
outcomes with routine coronary angiography [7].
Monaco and colleagues randomised 208 patients sched-
uled for elective AAA repair [11]. By using the RCRI, pa-
tients with ≥2 risk factors were randomly assigned to either
a selective or a systematic strategy. The patients in the se-
lective strategy group underwent non-invasive stress testing
first followed by coronary angiography only if a preceding
stress test was abnormal; approximately 41 % of patients in
this group underwent revascularisation. In the systematic
strategy group, all patients underwent coronary angiogra-
phy without a preceding stress test; approximately 58 % of
the patients in this group underwent revascularisation. Al-
most all patients in both groups underwent complete revas-
cularisation. At a follow-up of almost five years, patients in
the systematic group had improved survival (p = 0.01), as
well as freedom from major adverse cardiovascular events
(p = 0.003). This study highlights two potential points.
Firstly, it did not use the patients’ functional capacity in de-
termining stress testing vs coronary angiography, contrary
to the current ACC/AHA guideline recommendations. Sec-
ondly, it reinforces the approach that patients with evidence
of clinically significant atherosclerosis elsewhere may ben-
efit from direct angiography in detecting significant CAD
without prior stress testing. The fact that routine coronary
angiography showed better survival when compared with
prior stress testing may be explained in theory by two po-
tential reasons. Firstly, the risk of a false-negative stress
test is abolished; of note, underestimation of CAD in these
patients, possibly due to ‘balanced’ ischaemia, has been
reported with the use of non-invasive testing [32]. Sec-
ondly, the pathophysiological mechanism of perioperative
myocardial ischaemia could be entirely different from that
of the stress induced during the stress testing, as explained
above.
Stress-based approach
In a retrospective analysis, Landesberg et al. found that
patients who had moderate-to-severe ischaemia on preop-
erative thallium perfusion scanning and underwent coronary
revascularisation had better long-term survival when com-
pared with patients who did not undergo revascularisation
[9]. In contrast to the CARP trial where only one-third of
the enrolled patients had three-vessel CAD and all patients
with left main disease were excluded, 73 % of patients in
this retrospective trial had left main or triple-vessel CAD.
In addition, it also compared patients with normal, mild,
and moderately severe but fixed perfusion deficits and con-
cluded that results on preoperative thallium scanning can
predict perioperative mortality. On the other hand, all pa-
tients undergoing major vascular surgery underwent thal-
lium scanning as a routine, rather than risk stratification
and assessment of functional capacity. Age, type of vascu-
lar surgery, previous MI and presence of diabetes were in-
dependent predictors of mortality. In another retrospective
study by the same group, patients with abnormal myocar-
dial perfusion studies undergoing major vascular surgery
were divided into low, intermediate and high-risk categories
based on risk factors (age, diabetes, cerebrovascular dis-
ease, ischaemic heart disease, congestive heart failure, ST
depression on pre-op ECG and renal insufficiency) [10]. As
expected, patients in the intermediate and high-risk groups
had worse survival; however, preoperative coronary revas-
cularisation following an abnormal thallium scan improved
long-term survival in the intermediate risk group only.
Recently, a retrospective analysis on 1104 patients was
completed. It demonstrated that when compared with
patients with non-revascularised CAD, patients who had
undergone coronary revascularisation had a significant
improvement in perioperative cardiac mortality [33]. How-
ever, overall mortality did not change with coronary revas-
cularisation. This was mainly attributed to non-cardiac
peripheral vascular adverse events.
Discussion
In summary, the pathophysiology of perioperative MI is
complex, and is attributable to both a primary coronary
plaque disruption as well as a demand-supply mismatch
triggered by the haemodynamic effects of surgery owing to
a high catecholamine state. In patients with stable CAD and
excellent exercise tolerance (>10 METS), current guide-
lines do not recommend further testing, while those with
low or unknown functional capacity should undergo phar-
macological testing if it will change the management in
case of elective surgery. The jury is still out for patients
with a moderate functional capacity (4-10 METS) [1].
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What remains unclear is how the stress of surgery itself
correlates with the described METS used to gauge func-
tional capacity, given the varied mechanisms involved in
perioperative myocardial ischaemia. Although functional
capacity may predict the extent of oxygen demand-supply
mismatch inducible by physical activity, what it fails to pre-
dict is the pro-thrombotic and pro-inflammatory changes in
the perioperative period, which may contribute to cardiac
ischaemic events. It is difficult to quantify the ‘stress’ that
these factors may exert on the coronary vasculature and
hence using functional capacity measurements by exercise
capacity alone may be inadequate in predicting periopera-
tive outcomes. In addition, the role of functional assessment
of CAD by induced stress vs anatomical assessment using
coronary calcium scoring has also been recently described.
Patients with calcified atherosclerotic plaques even in the
absence of inducible perfusion defects have shown an in-
creased risk for adverse cardiovascular events [34]. It may
be argued that atherosclerosis is a progressive process with
multiple organ involvement; hence patients with significant
atherosclerotic disease elsewhere, even in the absence of
clinical symptoms of CAD, may actually have significant
disease. Given these limitations of stress testing, preoper-
ative angiography in high-risk patients (RCRI >3) under-
going elevated-risk surgery (NSQIP risk of MI and cardiac
arrest >1 %) may be beneficial [35].
For patients determined to be at a low risk for
major adverse cardiac events (NSQIP risk <1 %), it may be
reasonable to proceed with surgery without stress testing
and/or coronary angiography, with optimisation of medi-
cal therapy. On the other hand, in patients deemed high
risk, especially those with poor functional capacity, future
studies will need to address whether a selective strategy
using a stress test first versus routine coronary angiogra-
phy guided management could provide a more desirable
perioperative outcome of low incidence of MACE. The
next question is that based on coronary angiography, which
patients would benefit from revascularisation: only those
with multi-vessel disease, those with proximal left ante-
rior descending artery or those requiring coronary bypass
grafting. The answers to these questions remain debatable,
hence the level of evidence is C (expert opinion) in the most
recent ACC/AHA guideline when it comes to preoperative
coronary revascularisation calling for further studies. What
is interesting is that the latest ACC/AHA guidelines did
not incorporate the data from relatively recent trials where
routine coronary angiography was utilised [11, 12].
Nevertheless, based on the literature reviewed, the au-
thors of this review would lean toward a lower thresh-
old routine angiography and revascularisation as clinically
deemed appropriate for high-risk patients undergoing high-
risk surgery. In this scenario, although prior stress testing
might be helpful, lack of inducible ischaemia may lead to
underestimation of the potential risk and possible benefit of
coronary revascularisation. Even though the primary end-
point was negative, patients undergoing ‘complete’ revas-
cularisation derived perioperative benefit in the CARP trial
[31]. For patients determined to be at intermediate risk,
however, it may be beneficial to conduct stress testing fol-
lowed by angiography and revascularisation if the test is
moderately or severely abnormal. Inarguably, further large
randomised controlled trials comparing routine coronary
angiography versus the current ACC/AHA and ESC guide-
lines would help in caring for these complex patient subsets.
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